Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven recurrent or refractory pediatric solid tumor~* Bone marrow metastases allowed~PATIENT CHARACTERISTICS:~Age:~* 1 to 30~Performance status:~* 0-2~Life expectancy:~* At least 2 months~Hematopoietic:~* Absolute neutrophil count at least 1,000/mm3~* Platelet count at least 100,000/mm3 (transfusion independent)~* Hemoglobin at least 10 g/dL (RBC transfusion allowed)~Hepatic:~* Bilirubin no greater than 1.5 times normal~* SGOT no greater than 2.5 times normal~Renal:~* Adequate renal function as defined by one of the following:~  * GFR by creatinine clearance~ * Radioisotope GFR~ * Iothalamate at least 70 mL/min~Cardiovascular:~* Adequate cardiac function as defined by one of the following:~  * Ejection fraction at least 55% by MUGA~ * Fractional shortening at least 28% by echocardiogram~Neurologic:~* Adequate CNS function as defined by:~  * Seizure disorder, if present, controlled by anticonvulsants~ * CNS toxicity no greater than grade 2~Other:~* No uncontrolled infections~* Not pregnant or nursing~* No allergy to platinum compounds~* No history of allergy to etoposide (unless mobilization phase not required)~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Recovered from prior immunotherapy~* At least 1 week since prior cytokines~* At least 3 months since prior bone marrow or peripheral blood stem cell transplantation~* No concurrent immunomodulator~* No concurrent cytokines~Chemotherapy:~* At least 3 weeks (6 for nitrosourea) since prior chemotherapy and recovered~* No prior thiotepa~* No other concurrent chemotherapy~Endocrine therapy:~* Not specified~Radiotherapy:~* Recovered from prior radiotherapy~* At least 6 months since prior total body irradiation conditioning~* No concurrent radiotherapy to greater than 10% of total liver, lung, or bone marrow~Surgery:~* Not specified

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 30 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).